ASMB
NASDAQ · Biotechnology
Assembly Biosciences Inc
$27.37
+0.42 (+1.56%)
Open$26.83
Previous Close$26.95
Day High$27.90
Day Low$26.55
52W High$39.71
52W Low$11.64
Volume—
Avg Volume155.0K
Market Cap472.65M
P/E Ratio—
EPS$-1.93
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-60.1% upside
Current
$27.37
$27.37
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 111.37M | 44.93M | 300.07M |
| Net Income | -9,430,474 | -56,963,075 | 8.49M |
| Profit Margin | -8.5% | -133.8% | 2.8% |
| EBITDA | -18,467,220 | -67,781,254 | 15.38M |
| Free Cash Flow | — | — | 12.77M |
| Rev Growth | — | +65.8% | +3.4% |
| Debt/Equity | — | — | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |